Bimosiamose Inhalation: Phase IIa data

In a double-blind, cross-over, German Phase IIa trial in 18 healthy volunteers with ozone-induced airway inflammation, twice-daily inhaled Bimosiamose for 4 days was well tolerated and produced a sig...